Link to scroll to top of page

Q1 2026 Earnings Recap: Disney, Uber, Novo Nordisk and CVS Headline Broad Pre-Market Beats; Healthcare and Consumer Strength Define the Tape

U.S. earnings beats set positive market tone as Disney, Uber, CVS, and Novo Nordisk top expectations.

Stock Earnings Results

Table of Contents

A broad slate of U.S. companies reported stronger-than-expected quarterly results before Wednesday’s opening bell, with healthcare, consumer, industrial and select technology names helping set a positive tone for the session.

More than 100 companies reported results, with earnings beats outnumbering misses across most major sectors. Walt Disney (NYSE: DIS), Uber Technologies (NYSE: UBER), CVS Health (NYSE: CVS), and Novo Nordisk (NYSE: NVO) were among the key names topping estimates, while healthcare delivered some of the largest upside surprises.

Disney reported fiscal second-quarter earnings of $1.57 per share, above estimates of $1.49, on revenue of $25.17 billion. CVS Health posted adjusted earnings of $2.57 per share, well above expectations, on revenue of $100.43 billion, suggesting strength across its pharmacy, insurance and care delivery businesses.

Uber reported earnings of $0.72 per share, ahead of expectations, while revenue grew 14.5% year-over-year to $13.20 billion, reflecting continued demand across ride-hailing and delivery.

Novo Nordisk Anchors Healthcare Outperformance

Healthcare was the standout sector, led by Novo Nordisk, which reported earnings of $1.04 per share, above expectations of $0.87, as revenue rose 37.7% to $15.17 billion. The results pointed to continued strong demand for the company’s GLP-1 drugs.

Oscar Health also posted a sharp earnings beat, reporting $2.07 per share versus expectations of $1.21, with revenue rising 52.6%. BeOne Medicines, Insulet and Madrigal Pharmaceuticals also delivered strong growth, supported by demand across oncology, diabetes technology and MASH treatment markets.

The sector was not uniformly positive. United Therapeutics missed earnings expectations as revenue declined, while TG Therapeutics missed on earnings despite strong revenue growth. BioCryst Pharmaceuticals also swung to a loss against expectations for a small profit.

The results showed widening dispersion within healthcare, with investors rewarding companies tied to strong product demand and clear growth catalysts while punishing weaker earnings and margin disappointments.

Consumer, Industrial and Tech Results Show Selective Strength

Consumer-facing companies broadly showed resilience, with Marriott International beating estimates as travel demand remained firm. Restaurant Brands International, Dine Brands and Bloomin’ Brands also topped expectations, suggesting restaurants continue to hold pricing power despite macro caution.

Packaged goods and consumer brands were mixed but generally stable. Kraft Heinz (NASDAQ: KHC), Reynolds Consumer Products (NASDAQ: REYN), and Utz Brands (NYSE: UTZ) beat estimates, while Freshpet missed slightly on earnings despite double-digit revenue growth. Apparel and lifestyle names also performed well, with Carter’s posting a large earnings beat and Steve Madden reporting 18% revenue growth.

Industrials produced broad earnings strength, helped by M&A and capital spending demand. Johnson Controls (NYSE: JCI), ITT (NYSE: ITT), BorgWarner (NYSE: BWA), Timken (NYSE: TKR), Littelfuse (NASDAQ: LFUS), and Kennametal (NYSE: KMT) all topped estimates, while Amcor and HNI posted outsized revenue growth tied to recent acquisitions.

Energy results were more mixed. Several companies beat earnings expectations while missing or showing softer revenue, suggesting cost controls helped offset weaker commodity-linked top-line trends. Equinor and Cenovus beat on earnings despite revenue declines, while EOG Resources and NRG Energy missed profit estimates.

In technology and media, New York Times, Trimble, Flex and Criteo beat expectations, while Instacart missed slightly on earnings but posted 13.6% revenue growth. SolarEdge narrowed losses as revenue rose 41.5%, pointing to possible stabilization in residential solar demand.

The broader takeaway is that earnings power remains intact, but the market is becoming more selective. Healthcare winners, travel names, restaurants, industrial companies tied to M&A or capex, and AI infrastructure beneficiaries are showing strength, while weaker biotech, housing-linked, and commodity-sensitive names continue to face pressure.

Platforms like LevelFields track activist investor stake, layoffs, earnings, strategic events, and dividends, helping investors identify when clusters like this have historically aligned with sector-wide shifts.

Avi Baron
Avi Baron is a financial analyst at LevelFields AI, specializing in event-driven investing and corporate action research.

Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better investor.

Find Better Investments 1800x Faster

AI scans for events proven to impact stock prices, so you don't have to.

LEARN MORE

Free Trial: Signup for 1 Free Alert Per Week

Add your email to get alerts & the report.

Get 1 free alert per week via email

Upgrade if you want more or platform access

We'll also send you a free report

or Click Here to get full access now

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.